Skip to content

To Evaluate the efficacy of Pippalyadi Nasal Spray in Allergic Rhinitis

PHARMACEUTICO- ANALYTICAL AND CLINICAL STUDY OF PIPPALYADI NASAL SPRAY IN VATAJA PRATISHYAYA WITH SPECIAL REFERENCE TO ALLERGIC RHINITIS - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/04/084097
Enrollment
40
Registered
2025-04-04
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

None listed

Sponsors

Dr Chethan Kumar R
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Subjects fulfilling the diagnostic criteria 2.Subjects of all gender aged between 18-60 years will be selected 3.Subjects fit for Vataja Pratishyaya(Allergic Rhinitis).

Exclusion criteria

Exclusion criteria: 1.Subjects with Nasal polyp, Epistaxis and previous history of surgery for Nasal and paranasal sinuses are excluded. 2.Subjects having any systemic diseases. 3.Other types of Rhinitis like Atrophic Rhinitis and Rhinitis Sicca, Rhinosporidiosis and Infective Rhinitis. 4.Pregnant Women and Lactating Mothers.

Design outcomes

Primary

MeasureTime frame
Relief of Symptoms of Vataja Pratishyaya(Allkergic RhinitisTimepoint: 2nd day, 8th day, 15th day

Secondary

MeasureTime frame
TNSS Score reduction Nasal Cytology cel count reduction Reduction in Turbinatr HyprtrophyTimepoint: 28days

Countries

India

Contacts

Public ContactDr Nischitha M S

JSS AYURVEDA MEDICAL COLLEGE AND HOSPITAL

drnischitha@gmail.com9448673838

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026